15-YEAR ALL-CAUSE MORTALITY (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) AMONG MEN WITH BIOPSY GLEASON 2-6 CANCERS

被引：0
|
作者：
Bianco, Fernando
Scardino, Peter
Eastham, James
Wood, David
Klein, Eric
Stephenson, Andrew
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1093
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
992
引用
收藏
页码：E404 / E404
页数：1
相关论文
共 50 条
  • [1] ASSOCIATION OF THE NUMBER OF LYMPH NODES (LN) REMOVED AT RADICAL PROSTATECTOMY WITH ALL-CAUSE (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM)
    Abd el-Latif, Ahmed
    Stephenson, Andrew J.
    Klein, Eric A.
    Hernandez, Adrian V.
    Kattan, Michael W.
    Eggener, Scott E.
    Wood, David P.
    Eastham, James A.
    Scardino, Peter T.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E193 - E193
  • [2] Metformin Use and All-Cause and Prostate Cancer-Specific Mortality Among Men With Diabetes
    Margel, David
    Urbach, David R.
    Lipscombe, Lorraine L.
    Bell, Chaim M.
    Kulkarni, Girish
    Austin, Peter C.
    Fleshner, Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3069 - 3075
  • [3] Metformin Use and All-cause and Prostate Cancer-Specific Mortality Among Men with Diabetes
    Weckermann, Dorothea
    EUROPEAN UROLOGY, 2014, 66 (01) : 174 - 175
  • [4] Re: Metformin Use and All-Cause and Prostate Cancer-Specific Mortality among Men with Diabetes
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2014, 191 (06): : 1783 - 1783
  • [5] Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM).
    Brooks, Michael Austin
    Carlsson, Sigrid V.
    Zajichek, Alexander
    Chagin, Kevin M.
    Hugosson, Jonas
    Kattan, Michael W.
    Stephenson, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [6] RISK OF ALL-CAUSE AND PROSTATE CANCER-SPECIFIC MORTALITY AFTER BRACHYTHERAPY IN MEN WITH SMALL PROSTATE SIZE
    Nguyen, Paul L.
    Chen, Ming H.
    Choueiri, Toni K.
    Hoffman, Karen E.
    Hu, Jim C.
    Martin, Neil E.
    Beard, Claw J.
    Dosoretz, Daniel E.
    Moran, Brian J.
    Katin, Michael J.
    Braccioforte, Michelle H.
    Ross, Rud
    Salenius, Sharon A.
    Kantoff, Philip W.
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1318 - 1322
  • [7] Energetic risk and prostate cancer-specific and all-cause mortality in two large cohorts of men with localized prostate cancer
    Ma, Jing
    Giovannucci, Edward
    Nguyen, Paul L.
    Qiu, Weiliang
    Chavarro, Jorge
    Rosner, Bernard
    Cook, Nancy R.
    Platz, Elizabeth A.
    Gaziano, J. Michael
    Pollak, Michael
    Stampfer, Meir J.
    CANCER RESEARCH, 2012, 72
  • [8] Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men
    McGrowder, Donovan
    Tulloch-Reid, Marshall K.
    Coard, Kathleen C. M.
    McCaw-Binns, Afette M.
    Ferguson, Trevor S.
    Aiken, William
    Harrison, Leroy
    Anderson, Simon G.
    Jackson, Maria D.
    CANCER CONTROL, 2022, 29
  • [9] Metformin use and all-cause and prostate-cancer-specific mortality among diabetic men
    Margel, David
    Urbach, David R.
    Lipscombe, Lorraine
    Bell, Chaim
    Kilkarni, Girish
    Austin, Peter
    Joshua, Anthony Michael
    Fleshner, Neil Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM)
    Russo, Andrea L.
    Chen, Ming-Hui
    Aizer, Ayal A.
    Hattangadi, Jona A.
    D'Amico, Anthony V.
    BJU INTERNATIONAL, 2012, 110 (07) : 973 - 979
12345